[EN] FEM1B PROTEIN BINDING AGENTS AND USES THEREOF<br/>[FR] AGENTS SE LIANT À LA PROTÉINE FEM1B ET UTILISATIONS ASSOCIÉES
申请人:UNIV CALIFORNIA
公开号:WO2021183431A1
公开(公告)日:2021-09-16
Disclosed herein, inter alia, are compounds for binding FEMIB protein and uses thereof. In an aspect, provided herein is a pharmaceutical composition including a compound as described herein and a pharmaceutically acceptable excipient.
Cobalt-catalyzed enantioselective reductive addition reaction of ketimine using α-chloro carbonyl electrophile has been developed to access diversified enantioenriched β-tertiary amino acid with excellent enantioselectivity and broad functional group tolerance. The synthetic utility of this protocol includes the efficient assembly of iterative amino acid units and oligopeptide.